Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 131

1.

Death from anaphylaxis to cisplatin: a case report.

Zweizig S, Roman LD, Muderspach LI.

Gynecol Oncol. 1994 Apr;53(1):121-2.

PMID:
8175010
[PubMed - indexed for MEDLINE]
2.

Anaphylaxis from intraperitoneal infusion of cisplatin: a case report.

Ozg├╝roglu M, Demir G, Demirelli F, Mandel NM.

Am J Clin Oncol. 1999 Apr;22(2):172-3.

PMID:
10199453
[PubMed - indexed for MEDLINE]
3.

[Life threatening anaphylaxis after repeated cisplatin administration: case report and neu therapy concepts].

Berg K, Grundmann U, Villena-Heinsen C, Wilhelm W, Mertzlufft F.

Zentralbl Gynakol. 1996;118(12):684-8. German.

PMID:
9082708
[PubMed - indexed for MEDLINE]
4.

Case report of anaphylaxis from cisplatin/paclitaxel and a review of their hypersensitivity reaction profiles.

Ciesielski-Carlucci C, Leong P, Jacobs C.

Am J Clin Oncol. 1997 Aug;20(4):373-5. Review.

PMID:
9256892
[PubMed - indexed for MEDLINE]
5.

Hypersensitivity reactions to cisplatin and carboplatin--a report on six cases.

Saunders MP, Denton CP, O'Brien ME, Blake P, Gore M, Wiltshaw E.

Ann Oncol. 1992 Jul;3(7):574-6.

PMID:
1498081
[PubMed - indexed for MEDLINE]
6.

Anaphylaxis to cisplatin: diagnosis and value of pretreatment in prevention of recurrent allergic reactions.

Goldberg A, Altaras MM, Mekori YA, Beyth Y, Confino-Cohen R.

Ann Allergy. 1994 Sep;73(3):271-2.

PMID:
7916549
[PubMed - indexed for MEDLINE]
7.

Safety of cisplatin after severe hypersensitivity reactions to carboplatin in patients with recurrent ovarian carcinoma.

Ottaiano A, Tambaro R, Greggi S, Prato R, Di Maio M, Esposito G, Scala F, Barletta E, Losito S, De Vivo R, Iaffaioli VR, Pignata S.

Anticancer Res. 2003 Jul-Aug;23(4):3465-8.

PMID:
12926091
[PubMed - indexed for MEDLINE]
8.

Anaphylaxis to carboplatin following multiple previous uncomplicated courses.

Sood AK, Gelder MS, Huang SW, Morgan LS.

Gynecol Oncol. 1995 Apr;57(1):131-2.

PMID:
7705695
[PubMed - indexed for MEDLINE]
9.

Anaphylactoid reactions with intraperitoneal cisplatin.

Hebert ME, Blivin JL, Kessler J, Soper JT, Oleson JR.

Ann Pharmacother. 1995 Mar;29(3):260-3.

PMID:
7606071
[PubMed - indexed for MEDLINE]
10.

Analysis of patients with epithelial ovarian cancer or fallopian tube carcinoma retreated with cisplatin after the development of a carboplatin allergy.

Dizon DS, Sabbatini PJ, Aghajanian C, Hensley ML, Spriggs DR.

Gynecol Oncol. 2002 Mar;84(3):378-82.

PMID:
11855873
[PubMed - indexed for MEDLINE]
11.

Hypersensitivity reaction to carboplatin: successful resolution by replacement with cisplatin.

Porzio G, Marchetti P, Paris I, Narducci F, Ricevuto E, Ficorella C.

Eur J Gynaecol Oncol. 2002;23(4):335-6.

PMID:
12214738
[PubMed - indexed for MEDLINE]
12.

Usefulness of skin testing with platinum salts to demonstrate lack of cross-reactivity between carboplatin and cisplatin.

Enrique E, Malek T, Castell├│ JV, de Mateo JA.

Ann Allergy Asthma Immunol. 2008 Jan;100(1):86. doi: 10.1016/S1081-1206(10)60410-3. No abstract available.

PMID:
18254488
[PubMed - indexed for MEDLINE]
13.

Acute hypersensitivity reactions to chemotherapy.

Labovich TM.

Semin Oncol Nurs. 1999 Aug;15(3):222-31. Review.

PMID:
10461707
[PubMed - indexed for MEDLINE]
14.

Cisplatin may be a valid alternative approach in ovarian carcinoma with carboplatin hypersensitivity. Report of three cases.

Libra M, Sorio R, Buonadonna A, Berretta M, Stefanovski P, Toffoli G, Mazzaglia G, Cordani N, Stivala F, Boiocchi M.

Tumori. 2003 May-Jun;89(3):311-3.

PMID:
12908789
[PubMed - indexed for MEDLINE]
15.

A case of ovarian endometrioid adenocarcinoma with a yolk sac tumor component.

Abe A, Furumoto H, Yoshida K, Nishimura M, Irahara M, Kudo E, Sano T.

Int J Gynecol Cancer. 2008 Jan-Feb;18(1):168-72. Epub 2007 Apr 26.

PMID:
17466041
[PubMed - indexed for MEDLINE]
16.

[Successful desensitization using cisplatin after carboplatin-associated hypersensitivity reactions in 3 cases with recurrent ovarian carcinoma].

Hosaka M, Ebina Y, Moriwaki M, Hara Y, Araki N, Todo Y, Takeda M, Watari H, Sakuragi N.

Gan To Kagaku Ryoho. 2007 Sep;34(9):1505-8. Japanese.

PMID:
17876157
[PubMed - indexed for MEDLINE]
17.

Use of cisplatin without desensitization after carboplatin hypersensitivity reaction in epithelial ovarian and primary peritoneal cancer.

Callahan MB, Lachance JA, Stone RL, Kelsey J, Rice LW, Jazaeri AA.

Am J Obstet Gynecol. 2007 Aug;197(2):199.e1-4; discussion 199.e4-5.

PMID:
17689649
[PubMed - indexed for MEDLINE]
18.

A combination of platinum and tamoxifen in advanced ovarian cancer failing platinum-based chemotherapy: results of a Phase II study.

Benedetti Panici P, Greggi S, Amoroso M, Scambia G, Battaglia FA, Gebbia V, Salerno G, Paratore MP, Mancuso S.

Int J Gynecol Cancer. 2001 Nov-Dec;11(6):438-44.

PMID:
11906546
[PubMed - indexed for MEDLINE]
19.

Initial experience with a novel desensitization strategy for carboplatin-associated hypersensitivity reactions: carboplatin-hypersensitivity reactions.

Markman M, Hsieh F, Zanotti K, Webster K, Peterson G, Kulp B, Spicel A, Belinson J.

J Cancer Res Clin Oncol. 2004 Jan;130(1):25-8. Epub 2003 Oct 15.

PMID:
14564516
[PubMed - indexed for MEDLINE]
20.

Weekly cisplatin and oral etoposide as treatment for relapsed epithelial ovarian cancer.

Meyer T, Nelstrop AE, Mahmoudi M, Rustin GJ.

Ann Oncol. 2001 Dec;12(12):1705-9.

PMID:
11843248
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk